Director, New Business Development (M&A)

We Are The People Who Give Possibilities Purpose BD is among the largest global medical technology companies in the world, advancing the world of health™ through innovation in design, engineering, manufacturing, and commercialization of MedTech products. Position Summary The Director, New Business Development (M&A) – Peripheral Interventions (PI) Business Unit shapes and executes inorganic growth initiatives, including acquisitions, licensing transactions, and strategic investments that support PI’s long‑term growth priorities across its Vascular and Oncology platforms. The role is embedded in the business unit and collaborates closely with the PI Strategy team, platform leaders, and cross‑functional stakeholders. The Director owns the PI execution of external growth opportunities from early identification through diligence, governance approval, and integration planning, requiring strong strategic judgment, analytical rigor, and executive‑level communication skills. Key Responsibilities Own and maintain an active New Business Development pipeline, spanning acquisitions, licensing opportunities, minority investments, and other strategic transaction structures. Identify, prioritize, and evaluate external growth opportunities aligned with PI’s strategy, portfolio gaps, and category leadership objectives. Lead end‑to‑end evaluation of transactions, including market assessment, investment thesis development, and financial modeling. Partner closely with the PI Strategy and platform marketing teams to ensure external opportunities are tightly aligned to strategic priorities, platform roadmaps, and adjacencies. Conduct market, competitive, and technology landscape analyses to assess standard of care, adoption dynamics, unmet needs, and competitive positioning. Build robust business cases, including market sizing, revenue forecasting, scenario analysis, and risk assessment. Lead cross‑functional diligence efforts in collaboration with Marketing, Sales, Finance, Legal, R&D, Medical Affairs, Regulatory, Quality, and Operations teams. Prepare clear, executive‑ready materials and present opportunities to senior leadership and governance forums. Represent the Peripheral Interventions business unit in initial discussions with potential acquisition, licensing, or investment targets. Support deal structuring and negotiation strategy in close partnership with Corporate Development, Finance, and Legal. Lead integration planning activities for transactions entering execution, ensuring readiness and effective handoff to operating and integration teams. Support Annual Strategic Review (ASR) and New Product Development (NPD) review processes related to the external innovation pipeline. Collaborate with Corporate Development and other Business Units to share best practices and support enterprise‑wide assessments, as appropriate. Operate initially as an individual contributor, with the opportunity to grow into a people leadership role as business needs and team structure evolve. Qualifications Bachelor’s degree in Business, Finance, Engineering, Life Sciences, or a related field required; MBA or other advanced degree preferred. Minimum of 10 years of professional experience, including roles across business development, strategy, marketing, finance, or product development; 2-3 years of management consulting experience preferred. Healthcare industry experience required; medical device experience strongly preferred. Demonstrated experience leading complex, cross‑functional initiatives and influencing decisions without direct authority. Strong analytical capability, including market modeling, financial analysis, forecasting, and scenario planning. Ability to evaluate new technologies, clinical approaches, and business models and assess alignment with platform and portfolio needs. Proven ability to synthesize complex information into clear, actionable recommendations for senior leadership. Excellent written and verbal communication skills with executive‑level presence. Strong business judgment and comfort operating in ambiguity with incomplete information. Ability to travel domestically and internationally approximately 15–20%. EEO Statement Becton, Dickinson, and Company is an Equal Opportunity Employer. We evaluate applicants without regard to race, color, religion, age, sex, creed, national origin, ancestry, citizenship status, marital or domestic or civil union status, familial status, affectional or sexual orientation, gender identity or expression, genetics, disability, military eligibility or veteran status, and other legally protected characteristics. #J-18808-Ljbffr